Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial (Q47857376)
Jump to navigation
Jump to search
scientific article published on 2 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial |
scientific article published on 2 August 2013 |
Statements
1 reference
Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial (English)
1 reference
Laurent Kodjikian
1 reference
Eric H Souied
1 reference
Gérard Mimoun
1 reference
Martine Mauget-Faÿsse
1 reference
Francine Behar-Cohen
1 reference
Evelyne Decullier
1 reference
Laure Huot
1 reference
Gilles Aulagner
1 reference
GEFAL Study Group
1 reference
2 August 2013
1 reference
1 reference
120
1 reference
11
1 reference
2300-2309
1 reference